Literature DB >> 7217965

Improvement in nerve condition after plasma exchange for Guillain-Barré syndrome.

D Rail, R Stark, M Swash, A Newland.   

Abstract

Mesh：

Year:  1980        PMID： 7217965      PMCID： PMC490792          DOI： 10.1136/jnnp.43.12.1147

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  4 in total

1.  Treatment of chronic relapsing Guillain-Barré syndrome by plasma exchange.

Authors:  R L Levy; R Newkirk; J Ochoa
Journal:  Lancet       Date:  1979-10-06       Impact factor: 79.321

2.  Circulating demyelinating factors in acute idiopathic polyneuropathy.

Authors:  S D Cook; P C Dowling; M R Murray; J N Whitaker
Journal:  Arch Neurol       Date:  1971-02

3.  Treatment of acute polyneuropathy by plasma exchange.

Authors:  R P Brettle; M Gross; N J Legg; M Lockwood; C Pallis
Journal:  Lancet       Date:  1978-11-18       Impact factor: 79.321

4.  Disseminated vasculomyelinopathy: an immune complex disease.

Authors:  L Reik
Journal:  Ann Neurol       Date:  1980-04       Impact factor: 10.422
  4 in total
  4 in total

1.  The clinical effect and the effect on serum IgG antibodies to peripheral nerve tissue of plasma exchange in patients wit Guillain-Barré syndrome.

Authors:  C A Vedeler; H Nyland; J Fagius; P O Osterman; R Matre; J A Aarli; R W Janzen; H Jacobsen; H Skre
Journal:  J Neurol       Date:  1982       Impact factor: 4.849

2.  Treatment of the Guillain-Barré syndrome by plasma exchange.

Authors:  C Kennard; A C Newland; A Ridley
Journal:  J Neurol Neurosurg Psychiatry       Date:  1982-09       Impact factor: 10.154

3.  The treatment of inflammatory polyneuropathy by plasma exchange.

Authors:  M L Gross; N J Legg; M C Lockwood; C Pallis
Journal:  J Neurol Neurosurg Psychiatry       Date:  1982-08       Impact factor: 10.154

4.  Plasma exchange for Guillain-Barré syndrome.

Authors:  J Tharakan; R E Ferner; R A Hughes; J Winer; M Barnett; E R Brown; G Smith
Journal:  J R Soc Med       Date:  1989-08       Impact factor: 18.000
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.